Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. (Q38339372)

2 September 2017

title

Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. (English)

1 reference

2 September 2017

Mei Hua Gao

1

1 reference

2 September 2017

Tong Tang

2

1 reference

2 September 2017

Tracy Guo

3

1 reference

2 September 2017

Shu Qiang Sun

4

1 reference

2 September 2017

James R Feramisco

5

1 reference

2 September 2017

H Kirk Hammond

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 July 2004

1 reference

Journal of Biological Chemistry

2 September 2017

published in

1 reference

2 September 2017

volume

279

1 reference

2 September 2017

issue

37

1 reference

2 September 2017

page(s)

38797-38802

1 reference

Increased expression of adenylylcyclase type VI proportionately increases beta-adrenergic receptor-stimulated production of cAMP in neonatal rat cardiac myocytes

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Adenylyl cyclase increases survival in cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Controlled expression of cardiac-directed adenylylcyclase type VI provides increased contractile function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Low- and high-level transgenic expression of beta2-adrenergic receptors differentially affect cardiac hypertrophy and function in Galphaq-overexpressing mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Characterization of proximal transcription regulatory elements in the rat phospholamban promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Coupling of hormonal stimulation and transcription via the cyclic AMP-responsive factor CREB is rate limited by nuclear entry of protein kinase A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

In vitro and in vivo promoter analyses of the mouse phospholamban gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

The human phospholamban gene: structure and expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Identification of a highly conserved region at the 5' flank of the phospholamban gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Phospholamban and cardiac contractile function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Targeting phospholamban by gene transfer in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of beta-agonist stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Interactions between phospholamban and beta-adrenergic drive may lead to cardiomyopathy and early mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

ATF3 enhances c-Jun-mediated neurite sprouting

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

ATF3 inhibits doxorubicin-induced apoptosis in cardiac myocytes: a novel cardioprotective role of ATF3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Transcriptional repressor activating transcription factor 3 protects human umbilical vein endothelial cells from tumor necrosis factor-alpha-induced apoptosis through down-regulation of p53 transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Involvement of transcriptional repressor ATF3 in acceleration of caspase protease activation during DNA damaging agent-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Role for activating transcription factor 3 in stress-induced beta-cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Use of chromatin immunoprecipitation to clone novel E2F target promoters

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

Distribution of NF-kappaB-binding sites across human chromosome 22

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M405701200

21 January 2018

Identifiers

DOI

10.1074/JBC.M405701200

1 reference

2 September 2017

1 reference